COMPLETE HEART-BLOCK DUE TO INTERLEUKIN-2 THERAPY

[1] Rosenberg, Lotze, Muul, Et al., A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or interleukin-2 alone, N Engl J Med, 316, pp. 889-897, (1987)

[2] Fisher, Coltman, Doroshow, Et al., Metastatic renal cell cancer treated with interlekin-2 and lymphokine-activated killer cells. A phase II clinical trial, Ann Intern Med, 108, pp. 518-523, (1988)

[3] West, Tauer, Yannelli, Marshall, Orr, Thurman, Oldham, Constant-infusion recombinant interleukin-2 in adoptive therapy of advanced cancer, N Engl J Med, 316, pp. 898-905, (1987)

[4] Samlowski, Ward, Craven, Freedman, Severe myocarditis following high-dose interleukin-2 administration, Arch Pathol Lab Med, 113, pp. 838-841, (1989)

[1] Rosenberg, Lotze, Muul, Et al., A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or interleukin-2 alone, N Engl J Med, 316, pp. 889-897, (1987)

[2] Fisher, Coltman, Doroshow, Et al., Metastatic renal cell cancer treated with interlekin-2 and lymphokine-activated killer cells. A phase II clinical trial, Ann Intern Med, 108, pp. 518-523, (1988)

[3] West, Tauer, Yannelli, Marshall, Orr, Thurman, Oldham, Constant-infusion recombinant interleukin-2 in adoptive therapy of advanced cancer, N Engl J Med, 316, pp. 898-905, (1987)

[4] Samlowski, Ward, Craven, Freedman, Severe myocarditis following high-dose interleukin-2 administration, Arch Pathol Lab Med, 113, pp. 838-841, (1989)